Last updated on October 2018

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)


Brief description of study

This study comprises three sub-studies. The objective of sub-study 1 is to characterize the dose-response, efficacy, and safety of upadacitinib compared to placebo in inducing clinical remission in order to identify the induction dose of upadacitinib for further evaluation in sub-study 2. The objective of sub-study 2 is to evaluate the efficacy and safety of upadacitinib compared to placebo in inducing clinical remission in participants. The objective of sub-study 3 is to evaluate the efficacy and safety of upadacitinib compared to placebo in achieving clinical remission in participants who had a response following induction with upadacitinib.

Clinical Study Identifier: NCT02819635

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Hospital Universitario de San /ID# 155387
Medellin, Colombia
  Connect »

ABBVIE CALL CENTER

Hospital Pablo Tobon Uribe /ID# 159095
Medellín, Colombia
  Connect »

ABBVIE CALL CENTER

Instituto de Coloproctologia /ID# 152535
Medellin, Colombia
1.65miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.